Literature DB >> 16715425

Coronary artery bypass grafting under cardiopulmonary bypass in a patient with beta-thalassemia: report of a case.

Tetsuya Horai1, Keita Tanaka, Makoto Takeda.   

Abstract

We performed successful coronary artery bypass grafting under cardiopulmonary bypass (CPB) in a man with beta-thalassemia. Cardiopulmonary bypass for patients with hemoglobin disorders occasionally results in fatal hematologic complications. However, taking careful precautions such as transfusing stored autologous blood and administering haptoglobin may eliminate the need for allotransfusion, and prevent severe or persistent hemolysis and other complications. This case shows that cardiac surgery can be performed safely under CPB in patients with beta-thalassemia.

Entities:  

Mesh:

Year:  2006        PMID: 16715425     DOI: 10.1007/s00595-006-3184-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  7 in total

1.  Serum haptoglobins in hemolytic disorders.

Authors:  E C HERMAN
Journal:  J Lab Clin Med       Date:  1961-06

2.  [Cardiac surgery using cardiopulmonary bypass in a patient with sickle-cell trait].

Authors:  Y Ohashi; T Akamatsu; T Hirata; O Uchida; M Kuro
Journal:  Masui       Date:  1996-10

3.  Mechanical fragility of thalassaemic erythrocytes.

Authors:  P TOLENTINO
Journal:  Nature       Date:  1951-06-02       Impact factor: 49.962

4.  Haemoglobin H disease and cardiac surgery.

Authors:  S J Rowbottom; D A Sudhaman
Journal:  Anaesthesia       Date:  1988-12       Impact factor: 6.955

5.  Open heart surgery in patients with inherited hemoglobinopathies, red cell dyscrasias, and coagulopathies.

Authors:  M R deLeval; H F Taswell; E J Bowie; G K Danielson
Journal:  Arch Surg       Date:  1974-11

Review 6.  Hematologic complications of open heart surgery.

Authors:  N Wisch; R S Litwak; S B Luckban; J L Glass
Journal:  Am J Cardiol       Date:  1973-02       Impact factor: 2.778

7.  Open-heart surgery in sickle-cell haemoglobinopathies: report of 15 cases.

Authors:  D Métras; A O Coulibaly; K Ouattara; A Longechaud; P Millet; J Chauvet
Journal:  Thorax       Date:  1982-07       Impact factor: 9.139

  7 in total
  4 in total

Review 1.  Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.

Authors:  Dominik J Schaer; Paul W Buehler; Abdu I Alayash; John D Belcher; Gregory M Vercellotti
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

Review 2.  Mechanisms of haemolysis-induced kidney injury.

Authors:  Kristof Van Avondt; Erfan Nur; Sacha Zeerleder
Journal:  Nat Rev Nephrol       Date:  2019-08-27       Impact factor: 28.314

Review 3.  The role of red blood cells and cell-free hemoglobin in the pathogenesis of ARDS.

Authors:  David R Janz; Lorraine B Ware
Journal:  J Intensive Care       Date:  2015-06-17

4.  Saphenous Vein Graft Disease and Serum Erythropoietin Level.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Med Princ Pract       Date:  2016-03-28       Impact factor: 1.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.